Antonio Julià

27.3k citations
73 papers · 2.1k · 1 hit paper · h-index 25

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 11
    • Systemic Lupus Erythematosus Research 5

Antonio Julià

70 papers receiving 2.0k citations

Antonio Julià's Hit Papers

Analytical Methods in Untargeted Metabolomics: State of the Art in 2015 2015 · 487 citations
4870+3+7Years since publication100200300400

Peers

Antonio Julià
Comparison fields: 5 of 126
  • Hematology 297
  • Rheumatology 381
  • Genetics 164
  • Immunology 326
  • Molecular Biology 727
Replace Alan T. Remaley with:
Alan T. Remaley United States
Mark P. Fletcher United States
Gloria Gallo United States
Robert F. Ritchie United States
Laurie D. DeLeve United States
Richard I. Rynes United States
A M Waltersdorph United States
Peter Reizenstein Sweden
Claudio Avellini Italy
Mark Avigan United States
Antonio Julià relative to Alan T. Remaley United States Alan T. Remaley's profile →
Citations per field
00.5×1.5×2.2×
Alan T. Remaley · 1×
Citations per year

Countries citing papers authored by Antonio Julià

Since Specialization
Citations

This map shows the geographic impact of Antonio Julià's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Julià with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Julià more than expected).

Fields of papers citing papers by Antonio Julià

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Julià. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Julià. The network helps show where Antonio Julià may publish in the future.

Co-authors

The 25 scholars most cited alongside Antonio Julià, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Antonio Julià Line = papers co-authored together Antonio Julià links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
Hit paper breakdown →
2015487
2 1985110
3 2016104
4 202095
5 199190
6 200884
7 200975
8 197658
9 199154
10 201750
11 201348
12 201146
13 202043
14 199041
15 201641
16 201535
17 201735
18 201334
19 201433
20 200728

About Antonio Julià

Antonio Julià is a scholar working on Immunology, Rheumatology, Molecular Biology, Hematology and Oncology, having authored 73 papers that have together received 2.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Platelet Disorders and Treatments (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Systemic Lupus Erythematosus Research (5 papers), Blood groups and transfusion (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Eosinophilic Esophagitis (3 papers). The work is most often cited by research in Hematology (297 citations), Rheumatology (381 citations), Genetics (164 citations), Immunology (326 citations) and Molecular Biology (727 citations). Antonio Julià has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Sara Marsal, Arnald Alonso, L. Puig, Alba Erra, Juan D. Cañete, María López‐Lasanta, Chenicheri Balakrishnan, Carlos Palacio, Avron H. Ross and Antonio Fernández‐Nebro. Their work appears in journals such as PLoS ONE, British Journal of Haematology, Clinical and Experimental Rheumatology, Pharmacogenomics and The Pharmacogenomics Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact